Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRL | ELV | COR | ICLR | AVTR |
| Company | Charles River Laboratories Intl | Elevance Health Inc | Cencora Inc | Icon Plc | Avantor Inc |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NASDAQ | NYSE |
| Open | 235.28 | 538.65 | 227.72 | 313.77 | 24.87 |
| High | 236.88 | 539.76 | 228.25 | 314.05 | 24.89 |
| Low | 233.00 | 532.19 | 223.62 | 309.87 | 24.17 |
| Last | 235.29 | 533.35 | 224.11 | 311.75 | 24.28 |
| Change | -1.01 | -2.82 | -2.63 | -2.79 | -0.57 |
| % Change | -0.43% | -0.53% | -1.16% | -0.89% | -2.29% |
| Volume | 610,321 | 807,651 | 2,401,794 | 541,500 | 6,195,202 |
| 20-Day Average Volume | 491,545 | 1,101,215 | 1,543,625 | 596,455 | 5,169,730 |
| Previous Close | 236.30 | 536.17 | 226.74 | 314.54 | 24.85 |
| Industry | Medical Services | Medical Services | Medical Services | Medical Services | Medical Services |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 233.67 | 524.37 | 234.10 | 303.05 | 24.65 |
| 20-Day Raw Stochastic | 43.33% | 81.74% | 9.97% | 78.44% | 33.46% |
| 20-Day Relative Strength | 45.69% | 59.21% | 35.59% | 51.72% | 46.13% |
| Weighted Alpha | +21.52 | +20.08 | +27.42 | +49.88 | +20.96 |
| Today's Opinion | 24% Buy | 100% Buy | 24% Buy | 56% Buy | 40% Buy |
| Previous Opinion | 24% Buy | 100% Buy | 24% Buy | 56% Buy | 56% Buy |
| Last Month's Opinion | 80% Buy | 88% Buy | 80% Buy | 72% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.12% since 05/01/24 | +1.62% since 05/01/24 | -2.22% since 05/01/24 | +3.36% since 05/01/24 | -0.57% since 05/01/24 |
| Low | 225.74 on 05/02/24 | 518.90 on 05/03/24 | 222.20 on 05/03/24 | 295.75 on 05/02/24 | 23.93 on 05/02/24 |
| High | 238.38 on 05/03/24 | 539.76 on 05/08/24 | 228.79 on 05/02/24 | 317.24 on 05/07/24 | 24.99 on 05/07/24 |
| 1-Month | |||||
| %Chg | -7.70% since 04/08/24 | +4.58% since 04/08/24 | -6.76% since 04/08/24 | -2.87% since 04/08/24 | -5.41% since 04/08/24 |
| Low | 223.49 on 04/18/24 | 494.31 on 04/12/24 | 222.20 on 05/03/24 | 287.02 on 04/19/24 | 23.40 on 04/26/24 |
| High | 258.56 on 04/09/24 | 542.07 on 04/25/24 | 241.36 on 04/26/24 | 325.91 on 04/09/24 | 26.11 on 04/09/24 |
| 3-Month | |||||
| %Chg | +7.55% since 02/08/24 | +6.21% since 02/08/24 | -2.70% since 02/08/24 | +13.84% since 02/08/24 | +4.21% since 02/08/24 |
| Low | 216.50 on 02/13/24 | 492.06 on 03/01/24 | 222.20 on 05/03/24 | 272.14 on 02/13/24 | 21.68 on 02/13/24 |
| High | 275.00 on 03/08/24 | 542.07 on 04/25/24 | 246.75 on 04/03/24 | 344.77 on 03/06/24 | 26.16 on 03/25/24 |
| 6-Month | |||||
| %Chg | +33.71% since 11/08/23 | +17.69% since 11/08/23 | +13.88% since 11/08/23 | +20.84% since 11/08/23 | +32.53% since 11/08/23 |
| Low | 166.87 on 11/10/23 | 449.02 on 01/18/24 | 191.11 on 11/15/23 | 244.59 on 01/17/24 | 18.08 on 11/10/23 |
| High | 275.00 on 03/08/24 | 542.07 on 04/25/24 | 246.75 on 04/03/24 | 344.77 on 03/06/24 | 26.16 on 03/25/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 12,172,050 | 124,615,552 | 45,230,552 | 25,947,980 | 16,879,760 |
| Shares Outstanding, K | 51,511 | 232,418 | 199,482 | 82,495 | 679,266 |
| Annual Sales | 4,129,410,000 | 171,340,000,000 | 262,173,410,000 | 8,120,180,000 | 6,967,200,000 |
| Annual Net Income | 474,620,000 | 5,987,000,000 | 1,745,290,000 | 612,340,000 | 321,100,000 |
| Last Quarter Sales | 1,013,480,000 | 42,577,000,000 | 68,414,300,000 | 2,090,390,000 | 1,679,800,000 |
| Last Quarter Net Income | 187,080,000 | 2,246,000,000 | 420,780,000 | 187,440,000 | 60,400,000 |
| 60-Month Beta | 1.44 | 0.79 | 0.47 | 1.18 | 1.36 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.46 on 02/14/24 | 10.64 on 04/18/24 | 3.80 on 05/01/24 | 3.47 on 04/24/24 | 0.22 on 04/26/24 |
| Latest Earnings Date | 05/09/24 | 04/18/24 | 05/01/24 | 04/24/24 | 04/26/24 |
| Most Recent Dividend | N/A | 1.630 on 03/07/24 | 0.510 on 05/09/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 06/10/24 | 05/09/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 22.09 | 15.45 | 17.42 | 24.54 | 24.87 |